Why One Small Canadian Innovator Could Be a Top Growth Play Through 2029
When building a portfolio with a long runway for gains, identifying companies that combine real commercial traction with growth-oriented technology can be a powerful strategy. One such small-cap Canadian company stands out today: a medical-technology developer that is rapidly expanding the adoption of its incision-free treatment systems across North America and Europe. This company focuses…


